Skip to Main Content
(Press Enter)

Our Approach to ESG

At Bristol Myers Squibb, our vision is to transform the lives of patients through science. As a leading biopharma company, we understand our responsibility extends well beyond the discovery, development and delivery of innovative medicines that help patients prevail over serious diseases. We believe that driving long-term business value is at the heart of living our purpose—being leaders and difference-makers for generations to come. Our evolving ESG strategy builds on a legacy of comprehensive and global sustainability efforts, encompassing the products we make and how we make them, our facilities, our employees and our communities. We have been setting sustainability objectives and reporting on the results since the 1990s, when we first began reporting on environmental objectives. Today, our ESG strategy encompasses the following priority areas:

Ethical Business

  • Business ethics, integrity and compliance
  • COVID-19 response
  • Corporate governance
  • ESG governance
  • Product quality
  • Risk and crisis management
  • Supply chain management

Our People

  • Diversity and inclusion
  • Employee safety
  • Employee training and development
  • Employee wellness
  • Occupational health

Innovation, Health Equity and Patient Access

  • Access to healthcare and drug pricing
  • Clinical trial diversity and execution
  • Health Equity Initiative
  • Pipeline and digital innovation

Environmental Responsibility

  • Climate change
  • Environmental impacts
  • Pharmaceuticals in the Environment (PiE) and Anti-Microbial resistance (AMR)

Evolved ESG strategy

After successfully achieving our Sustainability 2020 Goals across the areas of patients, people, supply chain and the environment, we evolved our ESG strategy to reflect our ambition to integrate these efforts across our new company, inclusive of Celgene and MyoKardia. Our new ESG strategy seeks to mobilize our combined capabilities and resources to positively impact the communities where we live, work and serve, with four focus areas:

We are committed to quality, integrity and ethics in everything we do.

We operate with effective governance and the highest ethical standards. We seek transparency and dialogue with our stakeholders to improve our understanding of their needs.

We seek to actively improve the health of the communities where we live, work and serve.

Around the globe, we promote health equity and seek to improve health outcomes for populations disproportionately affected by serious disease.

We value diversity and inclusion.

We embrace the belief that diverse experiences and an inclusive culture yield transformative business results. The health, safety and respectful treatment of our workforce, as well as people development and work-life balance are among our highest priorities.

We honor our longstanding pledge to environmental sustainability.

We understand our responsibility to create maximum positive impact while minimizing our environmental footprint. We leverage sustainability to drive innovation, build resiliency and manage non-financial risks.

Accordingly, this report is written according to the four focus areas above. In each section, we have detailed how we approach the issue, who has ultimate oversight of it, our primary risks and opportunities and our 2020 performance. As we continue to evolve our reporting and enhance our disclosure in coming years, we will be guided by our commitment to transparency and impact.

Previous Download Report Next